Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7156-7162

  Westermarck, Jukka ^a,b   Li, Songping ^a   Jaakkola, Panu ^a   Kallunki, Tuula ^c   Grénman, Reidar ^a   Kähäri, Veli Matti ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 2;

ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MOUTH CARCINOMA; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; COLLAGENASES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENZYME ACTIVATION; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; INFANT, NEWBORN; LARYNGEAL NEOPLASMS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; MOUTH NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECOMBINANT PROTEINS; RNA; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034671479     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Matrix metalloproteinases in tumor invasion
2. Matrix metalloproteinases in squamous cell carcinomas
3. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutical implications
4. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
5. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer
6. Expression of the MMP-1 in human pancreatic carcinoma: Relationship with prognostic factor
7. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck
8. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas
9. Regulation of matrix metalloproteinase expression in tumor invasion
10. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites
11. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors
12. Signal transduction through MAP kinase cascades
13. Organization and regulation of mitogen-activated protein kinase signaling pathways
14. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum
15. Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells
16. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
17. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels
18. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways
19. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38
20. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development
21. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
22. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein
23. Structural organization and chromosomal localization of the mouse collagenase type I gene
24. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
25. Monocytic cell type-specific transcriptional induction of collagenase
26. Sequencing end-labeled DNA with base-specific chemical cleavage
27. Synthetic inhibitors of matrix metalloproteinases
28. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression
29. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromalepithelial cell interactions
30. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro
31. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
32. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
33. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
34. Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium
35. Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-α, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes
36. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas
37. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The lung cancer study group
38. 2-terminal kinase, p38s, and extracellular signal-regulated kinase 5
39. Transformation of mammalian cells by constitutively active MAP kinase
40. Hyperexpression of mitogen-activated protein kinase in human breast cancer
41. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma
42. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2
43. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase
44. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol esterinduced AP-1 activity without altering AP-1 site occupation in vivo
45. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
46. In vivo protein-DNA interactions at the c-jun promoter: Preformed complexes mediate the UV response
47. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation
48. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair
49. The Jun kinase 2 isoform is preferentially required for epidermal growth factor induced transformation of human A549 lung carcinoma cells